David Ian Wilson
CIK: 0002028949
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NEUP
Neuphoria Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Wilson David Ian
Wilson David Ian (SEC CIK 0002028949) files insider reports with the SEC as Director of Neuphoria Therapeutics Inc. (NEUP).
Signal8 holds 2 ownership filings by Wilson David Ian, all Form 4s, filed between Apr 18, 2025 and Jan 21, 2026. Those filings report 2 transactions, from Apr 16, 2025 to Jan 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wilson David Ian's filings is in BURLINGTON, MA.
Recent filings by Wilson David Ian
Other insiders filing for Neuphoria Therapeutics Inc. (NEUP)
- Davies Peter Miles Winston, Director
- Fisher Alan, Director
- Ryan Jane, Director
- Lynx1 Capital Management LP, 10% Owner
- Papapetropoulos Spyros, President and CEO